https://www.selleckchem.com/pr....oducts/mpp-iodide.ht
9; 33.9] at 5years (p = 0.003) (46/46). After RYGB, TWL% was lower in the craniopharyngioma group compared to the control group (p 0.001) and comparable after SG both at 1 and 5years. No difference between the two groups was observed in T2D remission rate and in early and late adverse events. No hormonal deficiency-related acute disease was reported. Bariatric surgery induced a significant weight loss in the craniopharyngioma group at 1 and 5years, but less than in common obesity. SG may be more effective than RYGB but this rema